Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Income Statement

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Abiomed Inc., consolidated income statement

US$ in thousands

Microsoft Excel
12 months ended: Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Revenue
Cost of revenue
Gross profit
Research and development
Selling, general and administrative
Acquired in-process research and development
Income from operations
Interest and other income, net
Interest expense
Income before income taxes
Income tax provision
Net income

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Income statement item Description The company
Revenue Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Abiomed Inc. revenue increased from 2020 to 2021 and from 2021 to 2022.
Income from operations The net result for the period of deducting operating expenses from operating revenues. Abiomed Inc. income from operations decreased from 2020 to 2021 and from 2021 to 2022.
Income before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Abiomed Inc. income before income taxes increased from 2020 to 2021 but then decreased significantly from 2021 to 2022.
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Abiomed Inc. net income increased from 2020 to 2021 but then decreased significantly from 2021 to 2022.